Corporate history Concordia Healthcare

1 corporate history

1.1 2013
1.2 2014
1.3 2015
1.4 2016

corporate history
2013

in may company acquired pediatric products (kapvay, orapred odt & os) shionogi inc. in october company acquired complete medical homecare, in december company completed takeover of mercari acquisition corp. pinnacle biologics inc, , began trading on toronto stock exchange.

2014

in january company completed five-year exclusive distribution deal lachlan pharma holdings distribute ulesfia united states. in march, company entered definitive agreement acquire irritable bowel syndrome drug, donnatal, revive pharmaceuticals $200 million , 4,605,833 common shares of company stock. deal completed in may. in september company entered first collaboration orphan canada. in same month company announced acquire zonegran in united states , puerto rico, $90 million.

2015

in march company announced largest acquisition date when agreed buy majority of assets of covis pharma sarl , covis injectables sarl $1.2 billion in cash. concordia acquired eighteen drugs part of transaction , anticipated 50% increase in earnings per share year.

in september, condordia paid european private equity firm cinven $3.5 billion in cash , shares uk-based global out-of-patent prescription pharmaceuticals firm amdipharm mercury - abbreviated amco. deal uniquely position combined company leading, international pharmaceutical company extensive geographic reach , said concordia chief executive mark thompson. 2015 year-over-year revenue growth of $289 million or increase of 276 per cent year-over-year adjusted ebitda1 growth of $206 million or increase of 347 per cent

2016

in february 2016, thompson transferred entire stock holdings ontario numbered company. in march, special committee set within company evaluate suitors takeover. each of suitors private equity firm. company not sold , in october 2016, company formally ended special committee. during time, thompson, via shares backed collateral loan, saw shares being sold on public market during august, september , october.

on september 15, 2016, british parliament proposed new bill, health service medical supplies (costs) bill bill addressed overcharging , members of parliament named amco unanimously approved october 24, 2016.

on october 21, 2016, company announced ceo mark thompson stepping down ceo , chairman of board.